KEGG   DRUG: Fitusiran sodium
Entry
D11810                      Drug                                   
Name
Fitusiran sodium (JAN);
Qfitlia (TN)
Product
Formula
C520H636F21N175O309P43S6.43Na
Exact mass
17185.1740
Mol weight
17193.40
Remark
Product: D11810<US>
Efficacy
Anthithrombin production inhibitor
  Disease
Hemophilia A or B [DS:H00219]
  Type
RNA interference (RNAi) drug
Target
SERPINC1 (AT3) [HSA:462] [KO:K03911]
  Pathway
hsa04610  Complement and coagulation cascades
Brite
Target-based classification of drugs [BR:br08310]
 Peptidases and inhibitors
  Peptidase inhibitors
   Serpin family
    SERPINC1 (AT3)
     D11810  Fitusiran sodium (JAN) <US>
New drug approvals in the USA [br08319.html]
 New molecular entities and new therapeutic biological products
  D11810
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D11810
Other DBs
PubChem: 405226675
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system